| Original language | English |
|---|---|
| Article number | e246 |
| Journal | Blood Cancer Journal |
| Volume | 4 |
| Issue number | 9 |
| DOIs |
|
| Publication status | Published - 1 Jan 2014 |
Cite this
}
Erratum : Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59). / Cummins, K. D.; Jane, S. M.; Ninkovic, S.; Bazargan, Ali; Filshie, Robin J A; Sutrave, G; Hertzberg, Mark; Scott, A.; Lane, S.; Yannakou, C. K.; Ritchie, Peter D.; D'Rozario, J.; Black, J.; Bavishi, Ketan; Wei, A.
In: Blood Cancer Journal, Vol. 4, No. 9, e246, 01.01.2014.Research output: Contribution to journal › Comment / Debate › Other › peer-review
TY - JOUR
T1 - Erratum
T2 - Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)
AU - Cummins, K. D.
AU - Jane, S. M.
AU - Ninkovic, S.
AU - Bazargan, Ali
AU - Filshie, Robin J A
AU - Sutrave, G
AU - Hertzberg, Mark
AU - Scott, A.
AU - Lane, S.
AU - Yannakou, C. K.
AU - Ritchie, Peter D.
AU - D'Rozario, J.
AU - Black, J.
AU - Bavishi, Ketan
AU - Wei, A.
PY - 2014/1/1
Y1 - 2014/1/1
UR - http://www.scopus.com/inward/record.url?scp=84927745055&partnerID=8YFLogxK
U2 - 10.1038/bcj.2014.68
DO - 10.1038/bcj.2014.68
M3 - Comment / Debate
VL - 4
JO - Blood Cancer Journal
JF - Blood Cancer Journal
SN - 2044-5385
IS - 9
M1 - e246
ER -